Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Repare Therapeutics Inc. | PRESIDENT AND CEO, Director | Common Shares | 108K | $498K | $4.63 | Apr 1, 2024 | Indirect |
Repare Therapeutics Inc. | PRESIDENT AND CEO, Director | Common Shares | 103K | $475K | $4.63 | Mar 28, 2024 | Direct |
Repare Therapeutics Inc. | PRESIDENT AND CEO, Director | Employee Stock Option (right to buy) | 237K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPTX | Repare Therapeutics Inc. | Mar 28, 2024 | 2 | -$23.8K | 4 | Apr 1, 2024 | PRESIDENT AND CEO, Director |
RPTX | Repare Therapeutics Inc. | Mar 25, 2024 | 3 | -$37.3K | 4 | Mar 27, 2024 | PRESIDENT AND CEO, Director |
RPTX | Repare Therapeutics Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 4, 2024 | PRESIDENT AND CEO, Director |
RPTX | Repare Therapeutics Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | President and CEO, Director |
RPTX | Repare Therapeutics Inc. | Jan 21, 2022 | 1 | $0 | 4/A | Jan 24, 2022 | President and CEO, Director |
RPTX | Repare Therapeutics Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | President and CEO |
RPTX | Repare Therapeutics Inc. | Jun 28, 2021 | 1 | -$54.9K | 4 | Jun 30, 2021 | President and CEO |
RPTX | Repare Therapeutics Inc. | Jun 9, 2021 | 1 | -$55.2K | 4 | Jun 10, 2021 | President and CEO |
RPTX | Repare Therapeutics Inc. | Jun 3, 2021 | 6 | -$1.27M | 4 | Jun 7, 2021 | President and CEO |
RPTX | Repare Therapeutics Inc. | May 20, 2021 | 1 | -$132K | 4 | May 21, 2021 | President and CEO |
RPTX | Repare Therapeutics Inc. | May 18, 2021 | 2 | -$196K | 4 | May 20, 2021 | President and CEO |